Abstract

Human monkeypox disease, a rare zoonosis endemic in Western and central Africa emerged in 56 different countries around the world with an increase of 77% in cases is a global concern. Natural animal reservoir of monkeypox virus is still unknown; rodents and primates except human are the probable source of virus introduction to human. A clear and sufficient data about the virulence and transmissibility of human monkeypox disease is limited due to inconsistence in the epidemiological studies. As per World Health Organisation and Centre for Disease Control status report smallpox vaccine is found to provide 85% immunity against human monkeypox disease. There is currently no specific treatment available and two antibiotic drugs tecovirimat and brincidofovir can be used as supportive treatment for time being. ©2022iGlobal Research and PublishingFoundation. All rights reserved.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.